Polymer drugs and polymeric drugs. IX. Synthesis and 5-fluorouracil release profiles of biodegradable polymeric prodrugs γ-poly(α-hydroxymethyl-5 -fluorouracil-glutamate)KISHIDA, A; GOTO, H; MURAKAMI, K et al.Journal of bioactive and compatible polymers. 1998, Vol 13, Num 3, pp 222-233, issn 0883-9115Article

Biochemical Modulation: Its Pharmacological Basis and Clinical ApplicationsLOW CHENG HOCK.Oncology. 1997, Vol 54, issn 0030-2414, 42 p., SUP1Conference Proceedings

Précision des préparations à base de cytostatiques : étude réalisée sur 3 unités centralisées de reconstitution = Precision of the cytotoxics preparations : study realized on 3 cytotoxics drug preparation unitGIRARD, F; MENAT, C; GUENFOUDI, M.-P et al.Journal de pharmacie clinique (Paris). 1999, Vol 18, Num 1, pp 62-63, issn 0291-1981Conference Paper

Comparative pharmacology of oral fluoropyrimidines: a focus on pharmacokinetics, pharmacodynamics and pharmacomodulationMILANO, G; FERRERO, J.-M; FRANCOIS, E et al.British journal of cancer. 2004, Vol 91, Num 4, pp 613-617, issn 0007-0920, 5 p.Article

Trabeculectomy with intraoperative sponge 5-fluorouracil in Afro-CaribbeansLACHKAR, Y; LEYLAND, M; BLOOM, P et al.British journal of ophthalmology. 1997, Vol 81, Num 7, pp 555-558, issn 0007-1161Article

Réactions allergiques après perfusion de 5 fluoro-uracile = Allergy after fluorouracil infusionLENOIR, B; LAFAY, J. P; GROSSO, V et al.La Lettre du cancérologue (Boulogne). 1997, Vol 6, Num 1, issn 1165-113X, p. 21Article

Needle revision of failing and failed trabeculectomy blebs with adjunctive 5-fluorouracil survival analysisBROADWAY, David C; BLOOM, Philip A; BUNCE, Catey et al.Ophthalmology (Rochester, MN). 2004, Vol 111, Num 4, pp 665-673, issn 0161-6420, 9 p.Article

Determination of 5-fluorouracil in microvolumes of human plasma by solvent extraction and high-performance liquid chromatographyLOOS, W. J; DE BRUIJN, P; VAN ZUYLEN, L et al.Journal of chromatography. B, Biomedical sciences and applications. 1999, Vol 735, Num 2, pp 293-297, issn 1387-2273Conference Paper

An accurate dihydrouracil/uracil determination using improved high performance liquid chromatography method for preventing fluoropyrimidines-related toxicity in clinical practiceREMAUD, Gaëlle; BOISDRON-CELLE, Michèle; HAMELINE, Catherine et al.Journal of chromatography. B. 2005, Vol 823, Num 2, pp 98-107, issn 1570-0232, 10 p.Article

Mutagenicity study of a new antineoplastic agent S-1, and its components, CDHP, and OxoOHUCHIDA, A; KOUCHI, Y; SATO, S et al.Journal of toxicological sciences. 1996, Vol 21, pp 675-689, issn 0388-1350, SUP3Article

Fluorodeoxyuridine modulates cellular expression of the DNA base excision repair enzyme uracil-DNA glycosylaseFISCHER, Jennifer A; MULLER-WEEKS, Susan; CARADONNA, Salvatore J et al.Cancer research (Baltimore). 2006, Vol 66, Num 17, pp 8829-8837, issn 0008-5472, 9 p.Article

Does intermittent pulse topical 5-fluorouracil therapy allow destruction of actinic keratoses without significant inflammation?EPSTEIN, E.Journal of the American Academy of Dermatology. 1998, Vol 38, Num 1, pp 77-80, issn 0190-9622Article

Tegafur-induced photosensitivity : evaluation of provocation by UVB irradiationUSUKI, A; FUNASAKA, Y; OKA, M et al.International journal of dermatology. 1997, Vol 36, Num 8, pp 604-606, issn 0011-9059Article

Case 1. Pseudomyxoma peritonei: Response to capecitabineLEVITZ, Jason S; SUGARBAKER, Paul H; LICHTMAN, Stuart M et al.Journal of clinical oncology. 2004, Vol 22, Num 8, pp 1518-1520, issn 0732-183X, 3 p.Article

Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidineSAKURAMOTO, Shinichi; SASAKO, Mitsuru; HIGASHINO, Masayuki et al.The New England journal of medicine. 2007, Vol 357, Num 18, pp 1810-1820, issn 0028-4793, 11 p.Article

Hiperpigmentación secundaria a capecitabina = Capecitabine induced hyperpigmentationVAZQUEZ-BAYO, C; RODRIGUEZ-BUJALDON, A. L; JIMENEZ-PUYA, R et al.Actas dermo-sifiliográficas (Ed. impresa). 2007, Vol 98, Num 7, pp 491-493, issn 0001-7310, 3 p.Article

How may anticancer chemotherapy with fluorouracil be individualised?PLOYLEARMSAENG, Su-Arpa; FUHR, Uwe; JETTER, Alexander et al.Clinical pharmacokinetics. 2006, Vol 45, Num 6, pp 567-592, issn 0312-5963, 26 p.Article

Relationship between in vitro activities of amphotericin B and flucytosine and pH for clinical yeast and mold isolatesTE DORSTHORST, D. T. A; VERWEIJ, P. E; MEIS, J. F. G. M et al.Antimicrobial agents and chemotherapy. 2005, Vol 49, Num 8, pp 3341-3346, issn 0066-4804, 6 p.Article

Oral capecitabine : Bridging the atlantic divide in colon cancer treatmentVAN CUTSEM, Eric; VERSLYPE, Chris; TEJPAR, Sabine et al.Seminars in oncology. 2005, Vol 32, Num 1, pp 43-51, issn 0093-7754, 9 p.Article

Clade-specific flucytosine resistance is due to a single nucleotide change in the FUR1 gene of Candida albicansDODGSON, Andrew R; DODGSON, Kirsty J; PUJOL, Claude et al.Antimicrobial agents and chemotherapy. 2004, Vol 48, Num 6, pp 2223-2227, issn 0066-4804, 5 p.Article

In vivo monitoring of capecitabine metabolism in human liver by ¹⁹fluorine magnetic resonance spectroscopy at 1.5 and 3 tesla field strengthVAN LAARHOVEN, Hanneke W. M; KLOMP, Dennis W. J; KAMM, Yvonne J. L et al.Cancer research (Baltimore). 2003, Vol 63, Num 22, pp 7609-7612, issn 0008-5472, 4 p.Article

A case of coronary spasm induced by 5-fluorouracilGORGULU, Sevket; CELIK, Seden; TEZEL, Tuna et al.Acta cardiologica. 2002, Vol 57, Num 5, pp 381-383, issn 0001-5385Article

The efficacy and pharmacoeconomic evaluation of 0.5% topical fluorouracil cream in treating actinic keratosesROBINS, Perry; GUPTA, Aditya K.Cutis (New York, NY). 2002, Vol 70, Num 2, issn 0011-4162, 36 p., SUPSerial Issue

Future treatment options with capecitabine in solid tumoursWILKE, H.European journal of cancer. Supplement (1990). 2002, Vol 38, Num 2, pp S21-S25, issn 1359-6349Article

Stabilité du mélange 5-fluoro-uracile-acide folinique : influence des concentrations, du contenant et de la forme de l'acide folinique = Stability of 5-fluorouracil-folinic acid mixture : influence of concentrations, container and form of folinic acidLOKIEC, F; AMIRAULT, P; BONNANS, H et al.Bulletin du cancer. 1999, Vol 86, Num 11, pp 946-954, issn 0007-4551Article